Medtecs International Corporation Ltd DRC (9103) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medtecs International Corporation Ltd DRC (9103) has a cash flow conversion efficiency ratio of -0.047x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-4.99 Million ≈ $-157.18K USD) by net assets (NT$107.19 Million ≈ $3.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medtecs International Corporation Ltd DRC - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Medtecs International Corporation Ltd DRC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Medtecs International Corporation Ltd DR total liabilities for a breakdown of total debt and financial obligations.
Medtecs International Corporation Ltd DRC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medtecs International Corporation Ltd DRC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Games Workshop Group PLC
LSE:GAW
|
0.512x |
|
Gascogne SA
PA:ALBI
|
0.011x |
|
Columbus Acquisition Corp Ordinary Shares
NASDAQ:COLA
|
-0.002x |
|
Future Vision II Acquisition Corporation Ordinary shares
NASDAQ:FVN
|
0.000x |
|
Münchener Tierpark Hellabrunn AG
MU:MTP
|
N/A |
|
Outcrop Gold Corp
V:OCG
|
-0.200x |
|
Sekar Laut Tbk
JK:SKLT
|
-0.004x |
|
Country View Bhd
KLSE:5049
|
0.325x |
Annual Cash Flow Conversion Efficiency for Medtecs International Corporation Ltd DRC (2009–2024)
The table below shows the annual cash flow conversion efficiency of Medtecs International Corporation Ltd DRC from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see 9103 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$107.05 Million ≈ $3.37 Million |
NT$312.00K ≈ $9.83K |
0.003x | +105.29% |
| 2023-12-31 | NT$130.31 Million ≈ $4.11 Million |
NT$-7.18 Million ≈ $-226.37K |
-0.055x | -107.22% |
| 2022-12-31 | NT$152.31 Million ≈ $4.80 Million |
NT$-4.05 Million ≈ $-127.69K |
-0.027x | -116.61% |
| 2021-12-31 | NT$187.91 Million ≈ $5.92 Million |
NT$30.10 Million ≈ $948.44K |
0.160x | -69.33% |
| 2020-12-31 | NT$194.49 Million ≈ $6.13 Million |
NT$101.59 Million ≈ $3.20 Million |
0.522x | +672.04% |
| 2019-12-31 | NT$64.59 Million ≈ $2.03 Million |
NT$4.37 Million ≈ $137.68K |
0.068x | -23.80% |
| 2018-12-31 | NT$63.35 Million ≈ $2.00 Million |
NT$5.62 Million ≈ $177.22K |
0.089x | +136.05% |
| 2017-12-31 | NT$62.92 Million ≈ $1.98 Million |
NT$2.37 Million ≈ $74.57K |
0.038x | -50.48% |
| 2016-12-31 | NT$61.86 Million ≈ $1.95 Million |
NT$4.70 Million ≈ $148.04K |
0.076x | -33.63% |
| 2015-12-31 | NT$60.46 Million ≈ $1.90 Million |
NT$6.92 Million ≈ $218.02K |
0.114x | -27.82% |
| 2014-12-31 | NT$56.24 Million ≈ $1.77 Million |
NT$8.92 Million ≈ $280.97K |
0.159x | +72.61% |
| 2013-12-31 | NT$56.53 Million ≈ $1.78 Million |
NT$5.19 Million ≈ $163.61K |
0.092x | +58.69% |
| 2012-12-31 | NT$56.56 Million ≈ $1.78 Million |
NT$3.27 Million ≈ $103.15K |
0.058x | -62.73% |
| 2011-12-31 | NT$54.60 Million ≈ $1.72 Million |
NT$8.48 Million ≈ $267.23K |
0.155x | +11.36% |
| 2010-12-31 | NT$53.45 Million ≈ $1.68 Million |
NT$7.46 Million ≈ $234.90K |
0.139x | -40.33% |
| 2009-12-31 | NT$50.65 Million ≈ $1.60 Million |
NT$11.84 Million ≈ $373.06K |
0.234x | -- |
About Medtecs International Corporation Ltd DRC
Medtecs International Corporation Limited, an integrated healthcare services provider, manufactures and distributes medical consumables for healthcare distributors, pharmaceutical companies, and hospital groups. It operates through Manufacturing, Hospital, and Distribution and Others segments. The Manufacturing segment produces and sub-contracts a range of medical consumables, including patients'… Read more